/ AMRX
/ Earnings
Amneal Pharmaceuticals (AMRX) Reports $617 Million in Q4 Revenue, Eyes Growth in 2024
Amneal Pharmaceuticals Inc. reported a slight increase in net revenue to $617 million for Q4 2023.
March 01, 2024
Amneal Pharmaceuticals Inc. reported a slight increase in net revenue to $617 million for Q4 2023.
March 01, 2024
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.